Cardlytics, Inc.
For the period ended Sep 30, 2025. Filed Nov 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 5, 2025
CDLX$1.63-10.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders' Equity (Unaudited)
Nine Months Ended September 30, 2025:
| AdditionalPaid-InCapital · AccumulatedOtherComprehensive Income (Loss) · AccumulatedDeficit · Total | ||||||
|---|---|---|---|---|---|---|
| Common Stock | ||||||
| Shares · Amount | ||||||
| Balance – December 31, 2024 | 51,257 | $10 | $1,366,958 | $3,601 | $(1,300,576) | $69,993 |
| Stock-based compensation | — | — | 25,733 | — | — | 25,733 |
| Settlement of restricted stock | 2,286 | — | — | — | — | — |
| Issuance of common stock pursuant to the 2018 ESPP (as defined below) | 263 | — | 447 | — | — | 447 |
| Other comprehensive loss | — | — | — | (5,639) | — | (5,639) |
| Net Loss | — | — | — | — | (95,238) | (95,238) |
| Balance – September 30, 2025 | 53,806 | $10 | $1,393,138 | $(2,038) | $(1,395,814) | $(4,704) |
Three Months Ended September 30, 2025:
| AdditionalPaid-InCapital · AccumulatedOtherComprehensive Loss · AccumulatedDeficit · Total | ||||||
|---|---|---|---|---|---|---|
| Common Stock | ||||||
| Shares · Amount | ||||||
| Balance – June 30, 2025 | 52,994 | $10 | $1,385,465 | $(3,628) | $(1,323,141) | $58,706 |
| Stock-based compensation | — | — | 7,673 | — | — | 7,673 |
| Settlement of restricted stock | 812 | — | — | — | — | — |
| Issuance of common stock pursuant to the 2018 ESPP (as defined below) | — | — | — | — | — | — |
| Other comprehensive income | — | — | — | 1,590 | — | 1,590 |
| Net Loss | — | — | — | — | (72,673) | (72,673) |
| Balance – September 30, 2025 | 53,806 | $10 | $1,393,138 | $(2,038) | $(1,395,814) | $(4,704) |
Nine Months Ended September 30, 2024:
| AdditionalPaid-InCapital · AccumulatedOtherComprehensiveIncome (Loss) · AccumulatedDeficit · Total | ||||||
|---|---|---|---|---|---|---|
| Common Stock | ||||||
| Shares · Amount | ||||||
| Balance – December 31, 2023 | 39,728 | $9 | $1,243,594 | $2,467 | $(1,111,272) | $134,798 |
| Exercise of common stock options | 3 | — | 5 | — | — | 5 |
| Stock-based compensation | — | — | 35,396 | — | — | 35,396 |
| Settlement of restricted stock | 2,869 | — | — | — | — | — |
| Issuance of common stock, net of issuance costs - ATM Offering Program (as defined below) | 3,908 | — | 48,151 | — | — | 48,151 |
| Issuance of common stock, net of issuance cost | 3,592 | — | 27,451 | — | — | 27,451 |
| Issuance of common stock pursuant to the 2018 ESPP (as defined below) | 242 | — | 1,461 | — | — | 1,461 |
| Termination of capped calls related to 2020 Convertible Senior Notes | — | — | 115 | — | — | 115 |
| Other comprehensive loss | — | — | — | (3,965) | — | (3,965) |
| Net Loss | — | — | — | — | (173,715) | (173,715) |
| Balance – September 30, 2024 | 50,342 | $9 | $1,356,173 | $(1,498) | $(1,284,987) | $69,697 |
Three Months Ended September 30, 2024:
| AdditionalPaid-InCapital · AccumulatedOtherComprehensiveIncome (Loss) · AccumulatedDeficit · Total | ||||||
|---|---|---|---|---|---|---|
| Common Stock | ||||||
| Shares · Amount | ||||||
| Balance – June 30, 2024 | 49,402 | $9 | $1,346,876 | $2,953 | $(1,139,805) | $210,033 |
| Stock-based compensation | — | — | 9,297 | — | — | 9,297 |
| Settlement of restricted stock | 940 | — | — | — | — | — |
| Other comprehensive loss | — | — | — | (4,451) | — | (4,451) |
| Net Loss | — | — | — | — | (145,182) | (145,182) |
| Balance – September 30, 2024 | 50,342 | $9 | $1,356,173 | $(1,498) | $(1,284,987) | $69,697 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.